Market Research Logo

Companion Diagnostics - Global Market Outlook (2015-2022)

Companion Diagnostics - Global Market Outlook (2015-2022)

According to Stratistics MRC, the Global Companion Diagnostics Market is accounted for $2.62 billion in 2015 and is expected to reach $9.27 billion by 2022 growing at a CAGR of 19.78% during the forecast period. At present, increasing demand for personalized medicine is mostly contributing to the global companion diagnostics market growth. On the other hand, cost allied with developing drugs could hamper the market. Developing companion diagnostics for several central nervous system conditions and hereditary conditions provide ample of opportunities for players in the market.

In terms of revenue, Breast cancer commanded the global companion diagnostics market. However, lung cancer is expected to lead the market in future growing at a significant CAGR owing to the discovery of biomarkers that are precise to lung cancer, and the discovery of myriad pertinent companion diagnostics. Molecular diagnostics is highest revenue generating segment and also expected to grow at a faster rate, mainly owing to the use of techniques such as real time PCR, In Situ Hybridization and next generation sequencing.

North America represented the largest market for companion diagnostics, followed by the Europe. The Asia Pacific and Rest of the World regions are anticipated to witness substantial demand for companion diagnostics in the future. In these regions, enhancing healthcare infrastructure, rising disposable incomes, and unexploited potential for companion diagnostics are cited as the major reasons for the market growth.

Some of the key players in the market include are Roche Diagnostics, Quest Diagnostics Inc.Qiagen N.V., Labcorp, Genomic Health Inc., Dako (Agilent Technologies), Celera, Biomerieux Sa, Abbott Laboratories, Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Biogenex Laboratories, Siemens and AstraZeneca.

Technologies Covered:
Molecular diagnostics
In Situ Hybridization (ISH)
CISH
FISH
Polymerase Chain Reaction (PCR)
Next generation sequencing
Other Technologies
Immunohistochemistry
Applications Covered:
Colorectal Cancer
Gastric Cancer
Lung Cancer
Breast Cancer
Melanoma
Other Applications
Indications Covered:
Cardiovascular conditions
Inflammation
Virology
Oncology
Other Indications
End User’s Covered:
Pharmaceutical Companies
Reference Lab
Physicians
Hospitals
Academic Medical Centers
Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Companion Diagnostics Market, By Technology
5.1 Introduction
5.2 Molecular diagnostics
5.2.1 In Situ Hybridization (ISH)
5.2.1.1 CISH
5.2.1.1.2 FISH
5.2.2 Polymerase Chain Reaction (PCR)
5.2.3 Next generation sequencing
5.2.4 Other Technologies
5.3 Immunohistochemistry
6 Global Companion Diagnostics Market, By Application
6.1 Introduction
6.2 Colorectal Cancer
6.3 Gastric Cancer
6.4 Lung Cancer
6.5 Breast Cancer
6.6 Melanoma
6.7 Other Applications
7 Global Companion DiagnosticsMarket, By Indication
7.1 Introduction
7.2 Cardiovascular conditions
7.3 Inflammation
7.4 Virology
7.5 Oncology
7.6 Other Indications
8 Global Companion DiagnosticsMarket, By End User
8.1 Introduction
8.2 Pharmaceutical Companies
8.3 Reference Lab
8.4 Physicians
8.5 Hospitals
8.6 Academic Medical Centers
9 Global Companion Diagnostics Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Roche Diagnostics
11.2 Quest Diagnostics Inc.
11.3 Qiagen N.V.
11.4 Labcorp
11.5 Genomic Health Inc.
11.6 Dako (Agilent Technologies)
11.7 Celera
11.8 Biomerieux Sa
11.9 Abbott Laboratories
11.10 Thermo Fisher Scientific, Inc.
11.11 Danaher Corporation
11.12 GE Healthcare
11.13 Biogenex Laboratories
11.14 Siemens
11.15 AstraZeneca
List of Tables
Table 1 Global Companion Diagnostics Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 3 Global Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Table 4 Global Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Table 5 Global Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 6 Global Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Table 7 Global Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 8 Global Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Table 9 Global Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 10 Global Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 11 Global Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Table 12 Global Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 13 Global Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 14 Global Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Table 15 Global Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 16 Global Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Table 17 Global Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Table 18 Global Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Table 19 Global Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Table 20 Global Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Table 21 Global Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Table 22 Global Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Table 23 Global Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Table 24 Global Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Table 25 Global Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Table 26 Global Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 27 Global Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
Table 28 North America Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 29 North America Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Table 30 North America Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Table 31 North America Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 32 North America Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Table 33 North America Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 34 North America Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Table 35 North America Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 36 North America Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 37 North America Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Table 38 North America Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 39 North America Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 40 North America Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Table 41 North America Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 42 North America Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Table 43 North America Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Table 44 North America Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Table 45 North America Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Table 46 North America Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Table 47 North America Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Table 48 North America Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Table 49 North America Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Table 50 North America Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Table 51 North America Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Table 52 North America Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 53 North America Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
Table 54 Europe Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 55 Europe Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Table 56 Europe Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Table 57 Europe Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 58 Europe Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Table 59 Europe Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 60 Europe Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Table 61 Europe Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 62 Europe Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 63 Europe Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Table 64 Europe Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 65 Europe Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 66 Europe Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Table 67 Europe Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 68 Europe Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Table 69 Europe Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Table 70 Europe Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Table 71 Europe Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Table 72 Europe Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Table 73 Europe Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Table 74 Europe Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Table 75 Europe Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Table 76 Europe Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Table 77 Europe Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Table 78 Europe Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 79 Europe Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
Table 80 Asia Pacific Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 81 Asia Pacific Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Table 82 Asia Pacific Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Table 83 Asia Pacific Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 84 Asia Pacific Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Table 85 Asia Pacific Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 86 Asia Pacific Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Table 87 Asia Pacific Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 88 Asia Pacific Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 89 Asia Pacific Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Table 90 Asia Pacific Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 91 Asia Pacific Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 92 Asia Pacific Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Table 93 Asia Pacific Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 94 Asia Pacific Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Table 95 Asia Pacific Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Table 96 Asia Pacific Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Table 97 Asia Pacific Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Table 98 Asia Pacific Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Table 99 Asia Pacific Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Table 100 Asia Pacific Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Table 101 Asia Pacific Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Table 102 Asia Pacific Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Table 103 Asia Pacific Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Table 104 Asia Pacific Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 105 Asia Pacific Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
Table 106 Rest of the World Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 107 Rest of the World Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Table 108 Rest of the World Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Table 109 Rest of the World Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 110 Rest of the World Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Table 111 Rest of the World Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 112 Rest of the World Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Table 113 Rest of the World Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 114 Rest of the World Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 115 Rest of the World Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Table 116 Rest of the World Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 117 Rest of the World Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 118 Rest of the World Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Table 119 Rest of the World Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 120 Rest of the World Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Table 121 Rest of the World Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Table 122 Rest of the World Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Table 123 Rest of the World Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Table 124 Rest of the World Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Table 125 Rest of the World Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Table 126 Rest of the World Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Table 127 Rest of the World Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Table 128 Rest of the World Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Table 129 Rest of the World Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Table 130 Rest of the World Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 131 Rest of the World Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report